Obesity and change in estimated GFR among older adults
- PMID: 19782454
- PMCID: PMC2787647
- DOI: 10.1053/j.ajkd.2009.07.018
Obesity and change in estimated GFR among older adults
Abstract
Background: The prevalence of chronic kidney disease is growing most rapidly among older adults; however, determinants of impaired kidney function in this population are not well understood. Obesity assessed in midlife has been associated with chronic kidney disease.
Study design: Cohort study.
Setting & participants: 4,295 participants in the community-based Cardiovascular Health Study, aged >or= 65 years.
Predictors: Body mass index, waist circumference, and fat mass measured using bioelectrical impedance.
Outcome: Change in glomerular filtration rate (GFR) during 7 years of follow-up.
Measurements: Longitudinal estimates of GFR calculated using the 4-variable Modification of Diet in Renal Disease (MDRD) Study equation.
Results: Estimated GFR decreased by an average of 0.4 +/- 3.6 mL/min/1.73 m(2)/y, and rapid GFR loss (>3 mL/min/1.73 m(2)/y) occurred in 693 participants (16%). Baseline body mass index, waist circumference, and fat mass were each associated with increased risk of rapid GFR loss: ORs, 1.19 (95% CI, 1.09-1.30) per 5 kg/m(2), 1.25 (95% CI, 1.16-1.36) per 12 cm, and 1.14 (95% CI, 1.05-1.24) per 10 kg after adjustment for age, sex, race, and smoking. The magnitude of increased risk was larger for participants with estimated GFR < 60 mL/min/1.73 m(2) at baseline (P for interaction < 0.05). Associations were substantially attenuated by further adjustment for diabetes, hypertension, and C-reactive protein level. Obesity measurements were not associated with change in GFR estimated using serum cystatin C level.
Limitations: Few participants with advanced chronic kidney disease at baseline, no direct GFR measurements.
Conclusion: Obesity may be a modifiable risk factor for the development and progression of kidney disease in older adults.
Figures




References
-
- Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. Jama. 2007;298(17):2038–2047. - PubMed
-
- Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352(20):2049–2060. - PubMed
-
- Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J. Association of Kidney Function and Albuminuria With Cardiovascular Mortality in Older vs Younger Individuals: The HUNT II Study. Arch Intern Med. 2007;167(22):2490–2496. - PubMed
-
- Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. Jama. 2004;291(7):844–850. - PubMed
-
- Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, Gaziano JM. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46(5):871–880. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01-HC-85085/HC/NHLBI NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- N01-HC-85081/HC/NHLBI NIH HHS/United States
- N01-HC-85086/HC/NHLBI NIH HHS/United States
- N01 HC055222/HL/NHLBI NIH HHS/United States
- N01-HC-55222/HC/NHLBI NIH HHS/United States
- N01-HC-8507982/HC/NHLBI NIH HHS/United States
- KL2 RR025015/RR/NCRR NIH HHS/United States
- UL1 TR000423/TR/NCATS NIH HHS/United States
- N01 HC075150/HL/NHLBI NIH HHS/United States
- N01 HC045133/HC/NHLBI NIH HHS/United States
- N01 HC035129/HC/NHLBI NIH HHS/United States
- 1KL2RR025015-01/RR/NCRR NIH HHS/United States
- N01-HC-8507983/HC/NHLBI NIH HHS/United States
- N01 HC015103/HC/NHLBI NIH HHS/United States
- N01 HC085086/HL/NHLBI NIH HHS/United States
- N01 HC085079/HL/NHLBI NIH HHS/United States
- N01-HC-75150/HC/NHLBI NIH HHS/United States
- N01-HC-85080/HC/NHLBI NIH HHS/United States
- N01-HC-85079/HC/NHLBI NIH HHS/United States
- N01-HC-85079-84/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources